The top five tweets: From Brexit to pharma reputations — what has engaged EPM readers this week?

by

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics.

5. In at five, this week is the positive outcome announcement for the trials evaluating Praluent.

4. Brexit and its regulatory implications make it into fourth position with this article from Schlafender Hase.

3. Taking the middle position is the news that the biosimilar Truxima is non-inferior to the reference product.

2. Coming in second place is the study from the Reputation Institute finding that pharma companies have strong reputations.

1. This week’s top spot goes to the launch of the fast track acceleration programme for life sciences start-ups.

Back to topbutton